Bristol-Myers Squibb Co. (BMY) News
Filter BMY News Items
BMY News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BMY News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest BMY News From Around the Web
Below are the latest news stories about BRISTOL MYERS SQUIBB CO that investors may wish to consider to help them evaluate BMY as an investment opportunity.
Bristol-Myers Squibb Company (BMY) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)Bristol-Myers Squibb Company (BMY) 43rd Annual J.P. Morgan Healthcare Conference January 13, 2024 10:30 AM ET Company Participants Chris Boerner - Chairman and Chief Executive Officer Conference Call Participants Chris Schott - JPMorgan Presentation Chris Schott Good morning everybody. I'm Chris Schott at J.P. Morgan, and it's great to see everyone again. It's my pleasure today to be introducing Bristol-Myers, who is again kicking off the J.P. Morgan Healthcare Conference. From the company, we have the company's Chairman and CEO, Chris Boerner. So Chris, Happy New Year. Thanks for joining us and looking forward to the presentation. Chris Boerne... |
AI, vaccine distrust, & the future of healthcare: Novartis CEOCan science prevail against this more turbulent backdrop of the Trump administration? Yahoo Finance executive editor Brian Sozzi talks at length with Novartis (NVS) CEO Vas Narasimhan. Narasimhan has led the drug giant since 2018, doing deals that have expanded the company’s pipeline in areas like heart disease and cancer. Still, Narasimhan is feeling pressure to bring the investments to the bottom line to jumpstart its stock price. In the last year, Novartis shares have declined 6.69%. During that same timespan, the S&P 500 and Dow Jones Industrial Average have gained 22.8% and 12%, respectively. The iShares U.S. Healthcare ETF (IYH) is up slightly in the past year. The stock prices of Pfizer (PFE) and Moderna (MRNA) are down 8.5% and 61%, respectively in the past year. For full episo... |
Bristol Myers Squibb (BMY) Stock Slides as Market Rises: Facts to Know Before You TradeBristol Myers Squibb (BMY) concluded the recent trading session at $56.81, signifying a -0.58% move from its prior day's close. |
How To Put $100 In Your Retirement Fund Each Month With Bristol-Myers Squibb StockBristol-Myers Squibb Company (NYSE:BMY) discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products worldwide. It will report its Q4 2024 earnings on Feb. 6, 2025. Wall Street analysts expect the company to ... |
J&J Pauses Sales of Atrial Fibrillation Device, Stock DownJ&J's MedTech unit pauses all cases of the Varipulse PFA system as part of an external evaluation. Stock dips. |
This Unpopular Dividend Stock Is a BuyLike a champion boxer on the ropes, Bristol-Myers Squibb (NYSE: BMY) finds itself in a challenging position. Specifically, the pharmaceutical giant's shares have declined by a disappointing 11.6% over the prior five years while the benchmark S&P 500 has delivered total returns of 97.5%, including dividends. The company also continues to navigate generic competition for its cancer drug Revlimid, which it acquired as part of its 2019 deal for cancer specialist Celgene. |
Bristol Myers Stock Gains 11.4% in a Year: Time to Buy or Sell?Bristol Myers stock has performed well in the past year, gaining 11%. We believe there is more room for further growth, and any dip in the share price can be used as a buying opportunity. |
Should Bristol-Myers Squibb Company (NYSE:BMY) Be In Your Early Retirement Portfolio?We recently compiled a list of the Early Retirement Portfolio: 10 Stocks to Live Off Dividends. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other stocks. As retirement approaches, ensuring financial stability becomes increasingly important for investors. Among the available investment options, consistent dividend payments […] |
Bristol-Myers Squibb (NYSE:BMY) Has A Pretty Healthy Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company... |
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a DecadeIf you're worried about having enough passive income to maintain your lifestyle during retirement, you're not alone. Filling your portfolio with dividend-paying stocks that raise their quarterly payouts faster than the underlying inflation rate could even lead to extra spending cash. Medtronic (NYSE: MDT), Bristol Myers Squibb (NYSE: BMY), and AbbVie (NYSE: ABBV) have many years of reliable dividend growth under their belts. |